EuroPCR 2023 Hotlines/Late-Breaking Trials: focus on wire and image-based physiology

Session comprising selected EuroPCR 2023 Late-Breaking Trial submissions

Anchorperson: P. Smits
Spokesperson: R. Al-Lamee
SHOW MORE

Summary

Find out more about a series of studies focusing on wire and image based physiology: Coronary microvascular function and CT coronary angiography trial aiming to assess whether endotype diagnosis informed by coronay function testing vs angiography improved angina; a 5-year follow up of the DEFINE FLAIR; the report from SCAAR about the use of FFR in chronic coronary syndrome; a 3-year follow-up of the randomised FAME 3 trial evaluating FFR-guided PCI vs CABG; Prognostic value of post-PCI QFR in the multinational randomized FLAVOUR trial; the accuracy of instantaneous wave-free derived from coronary angiography.

Presentations available when logged in:

  • Coronary microvascular function and CT coronary angiography trial
  • DEFINE-FLAIR: five-year follow-up
  • FFR in chronic coronary syndrome: a report from SCAAR
  • FFR-guided PCI vs. CABG - Three-year follow-up of the randomised FAME 3 trial
  • Prognostic value of post-PCI QFR in the randomized FLAVOUR trial
  • Accuracy of instantaneous wave-free ratio derived from coronary angiography